Abstract: The present invention relates to the field of wound healing. More specifically, the present invention provides methods and compositions useful for improved wound healing via autologous stem cell mobilization. In one embodiment, a method for improving wound healing in a patient comprises administering to the patient a therapeutically effective amount of a stem cell mobilizer and a low dose of an immunosuppressive agent.

Abstract: The present invention relates to an arrangement for point-to-point transmission over links between first and second link (end) terminals in a system implementing time division duplex (TDD) and wherein information is sent over the links in frames divided into time slots. It is adapted to determine the lengths of the frames on a per link basis using one or more link parameters, the frame length hence being variable.

Abstract: The present invention relates to a liquid (meth)acrylic syrup for impregnating a fibrous substrate. The present invention relates in particular to a viscous liquid syrup mainly containing methacrylic or acrylic components. The invention also relates to a process for manufacturing such a syrup. The invention also relates to a process for impregnating a fibrous substrate or long fibers with said viscous liquid syrup. The invention also relates to a fibrous substrate preimpregnated with said syrup, which is useful for manufacturing mechanical or structured parts or products. The present invention also relates to a manufacturing process for manufacturing mechanical or structured parts or articles and to three-dimensional mechanical or structured parts obtained by this process. The invention applies to the preparation of mechanical parts or structural elements made of fire-resistant thermoplastic composite material.

Abstract: An assembled fence includes a transverse bar, a vertical bar and a clip, wherein the clip is an elastic non-metal clip. Due to the installation of the elastic non-metal clip, all fence parts, including the clip, can be assembled in the assembly site; the clip which does not need to be assembled in the vertical bar in advance will not be damaged and is free from a problem of scratching other parts such as the vertical bar in a transportation process; and the non-metal clip is low in cost.

Abstract: A mouse device includes an upper cover, an intermediate cover, a lower cover, a circuit board, and two switches. Two protrusion posts of the upper cover are respectively penetrated through two perforations of the intermediate cover. Two first pivotal parts of the upper cover are respectively connected with two second pivotal parts of the intermediate cover. The upper cover is fixedly connected to an annular sidewall of the lower cover. The circuit board and the two switches are disposed on the lower cover. When the upper cover is rotated relative to the intermediate cover through the two first pivotal parts and two second pivotal parts, one of the two switches is triggered by the corresponding protrusion post so as to generate a corresponding electronic signal. The use of the present mouse device can prevent from introducing foreign matters, reduce the depressing force and avoid erroneously triggering the switch.

Abstract: Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.

Abstract: An assembled fence includes a transverse bar, a vertical bar and a clip, wherein the clip is an elastic non-metal clip. Due to the installation of the elastic non-metal clip, all fence parts, including the clip, can be assembled in the assembly site; the clip which does not need to be assembled in the vertical bar in advance will not be damaged and is free from a problem of scratching other parts such as the vertical bar in a transportation process; and the non-metal clip is low in cost.

Abstract: Cross-linked proteins and peptides, and methods of making and uses of such cross-linked proteins and peptides. The cross-linked proteins and peptides have rigid, distance-matching bismethylene aryl cross-linking moieties. Compositions comprising the cross-linked proteins and peptides can be used as pharmaceutical delivery formulations. The cross-linked proteins and peptides can have improved properties, such as cell permeability, as compared to the parent protein or peptide.

Abstract: A mouse device includes an upper cover, an intermediate cover, a lower cover, a circuit board, and two switches. Two protrusion posts of the upper cover are respectively penetrated through two perforations of the intermediate cover. Two first pivotal parts of the upper cover are respectively connected with two second pivotal parts of the intermediate cover. The upper cover is fixedly connected to an annular sidewall of the lower cover. The circuit board and the two switches are disposed on the lower cover. When the upper cover is rotated relative to the intermediate cover through the two first pivotal parts and two second pivotal parts, one of the two switches is triggered by the corresponding protrusion post so as to generate a corresponding electronic signal. The use of the present mouse device can prevent from introducing foreign matters, reduce the depressing force and avoid erroneously triggering the switch.

Abstract: Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.

Abstract: Peptide-peptidase inhibitor conjugate molecules are disclosed. These conjugate molecules are useful as agents for the treatment and prevention of metabolic and cardiovascular diseases, disorders, and conditions. Such diseases, conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, and other diabetes-related disorders.

Abstract: Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.

Abstract: Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.

Abstract: Peptide-peptidase inhibitor conjugate molecules are disclosed. These conjugate molecules are useful as agents for the treatment and prevention of metabolic and cardiovascular diseases, disorders, and conditions. Such diseases, conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, and other diabetes-related disorders.

Abstract: Methods for making coatings on an implantable device, such as a drug-eluting stent. The coatings comprise a polymer and a drug in a crystalline or partially crystalline form. In addition, implantable devices produced by the methods and methods of using the coated implantable devices are described.

Abstract: Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.